Ali Behbahani, M.D.

Ali Behbahani, M.D.

DirectoratBlack Diamond Therapeutics· In proxies 2023–2025

Ali Behbahani, M.D. sits on 12 public boards.

Boards1

  • Black Diamond TherapeuticsDirector · 7 yr on the boardIndependentAudit, Compensation (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Black Diamond TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +43%
  2. Monte Rosa Therapeutics, Inc.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  3. Korro Bio, Inc.Public company · 7 yr
    • Director2019 – Present · 7 yrNo stock prices for these years
  4. Spyglass Pharma, Inc.Public company · 7 yr
    • Director2019 – Present · 7 yrNo stock prices for these years
  5. CRISPR Therapeutics AGPublic company · 11 yr
    • Director2015 – Present · 11 yrNo stock prices for these years
  6. NKarta, Inc.Public company · 11 yr
    • Director2015 – Present · 11 yrNo stock prices for these years
  7. Adaptimmune TherapeuticsPublic company · 12 yr
    • Director2014 – Present · 12 yrNo stock prices for these years
  8. Arcellx, Inc.Public company
    • Director? – PresentNo stock prices for these years
  9. Genocea Biosciences, Inc.Public company
    • Director? – PresentNo stock prices for these years
  10. CVRx, Inc.Public company · 11 yr
    • Director2013 – 2024 · 11 yrNo stock prices for these years
  11. Minerva Surgical Inc.Public company · 13 yr
    • Director2011 – 2024 · 13 yrNo stock prices for these years
  12. Oyster Point Pharma, Inc.Public company · 6 yr
    • Director2017 – 2023 · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?